Recent articles
Here's Why Albemarle Dropped 12.3% in August
The company reported solid second-quarter 2019 operating results, but significantly reduced production expansion plans.
Here's Why Pattern Energy Group Rose 17.6% in August
The company confirmed that it has been approached for a takeover, but nothing is guaranteed.
2 Stocks to Watch in September
These two businesses could receive a big boost this month if certain events fall in their favor.
Here's Why Enphase Energy Keeps Tumbling
The solar-hardware stock has now given up all gains since second-quarter 2019 operating results were announced.
Here's Why Mallinckrodt Is Collapsing Today
The company is reportedly considering bankruptcy to cope with its financial exposure in the opioid crisis.
Where Will Epizyme Be in 1 Year?
The pharma company could earn its first drug approval in January 2020. What happens after that?
Merger or Not, Pacific Biosciences Needs to Deliver
The DNA sequencing pioneer promised a $1,000 human genome by early 2019. The price isn't so important, but the technology upgrades will prove critical.
Near an All-Time Low, Is Clovis Oncology a Buy?
Investors need ongoing clinical trials to deliver -- and for the business to rein in expenses.
Here's My Top Stock to Buy in September
The business is profitable, investing in the future, and pays a healthy annual dividend yielding 5%. Shares look like a bargain, too.
3 Stocks Peter Lynch Would Love
These growth stocks are trading at reasonable prices -- exactly the kind of investment the investing guru sought.
ArQule: Buy the Dip?
The pharma company has wowed investors with solid clinical data multiple times this year.
Neptune Wellness Solutions: Buy the Dip?
The business might yet prove to be a less risky play on the rise of cannabis, but it has plenty left to prove to investors.
3 Top Stocks Under $20
Your money can buy more shares of these promising companies thanks to an affordable stock price.
Here's Why Lannett Stock Is Soaring Today
The generic drug manufacturer announced fiscal 2019 results and inked an important supply deal.
3 Stocks to Buy and Hold for Decades
These businesses offer the potential for above-average returns that could receive a huge helping hand from the power of compound interest.
Here's Why Silver Stocks Are Soaring Again Today
The precious metal has been rising in price as global economic headwinds mount.
Iovance Biotherapeutics: Buy the Dip?
The company is flush with cash and wields a promising therapeutic pipeline. Is its recent tumble a buying opportunity?
Here's Why Mallinckrodt Fell Over 17% Today
The bad news keeps piling up.
Here's Why Oil and Gas Stocks Are Getting Crushed Today
China has decided that American oil exports, a relative strength in recent years, are fair game in the trade war.
3 Top Growth Stocks to Buy in the Final Month of Summer
The dog days of summer are finally behind us (on the calendar, anyway), but these three stocks offer sizzling growth potential.